Q Bio

Q Bio, based in San Carlos, California, is at the forefront of healthcare innovation with its development of the Gemini Digital Twin Platform. This platform integrates lab tests, genetics, anatomical data, medical history, wearable, and lifestyle data to create a comprehensive health map over time. The company has also created the Mark I, a full-body scanner capable of autonomously scanning the entire body in 10 minutes without radiation, breath holds, or claustrophobia. Another key technology is the Anatomical Foundation Model (AFM), an AI model designed to automatically analyze whole-body MRI scans and evaluate health risks. The Gemini Exam combines lab tests, genetics, and vitals with advanced MRI insights to provide a thorough physical exam, including non-invasive measurements clinically relevant for detecting common existential risks. The Gemini Dashboard allows users to explore their health data, including 3D whole body reconstructions and biomarkers, and securely share it with doctors. Q Bio’s technologies aim to automate the physical exam process from data collection to triage and routing, making preventive personalized healthcare accessible to everyone. The company is piloting the Gemini Exam at its research site in Redwood City, California, and partners with health systems to test its Digital Twin and quantitative MRI technologies. Q Bio’s approach focuses on proactive health forecasting using a Large Biological Model, aiming to make physical exams as cost-effective as operating a car wash, with a goal of conducting 20,000 exams annually. The company’s technologies operate at the intersection of AI, Physics, and Biology, working towards making the Star Trek Medbay a reality by automating the physical exam process. Currently, Q Bio’s technologies are being tested under research protocols and have not yet been approved by the FDA.